FREEMAN KEVIN D 4
4 · GALECTIN THERAPEUTICS INC · Filed Jun 20, 2024
Insider Transaction Report
Form 4
FREEMAN KEVIN D
Director
Transactions
- Purchase
Common Stock
2024-06-20$2.38/sh+2,500$5,950→ 28,469 total
Holdings
- 18,063(indirect: By IRA)
Common Stock
- 75,000(indirect: By LLC)
Common Stock
Footnotes (1)
- [F1]Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.